Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Function And Satisfaction of UbrogepanT-treated Migraine Patients in Canada (FAST): Prospective, Observational, Real-world Study

NCT06692881 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06692881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Function And Satisfaction of UbrogepanT-treated Migraine Patients in Canada (FAST): Prospective, Observational, Real-world Study
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
February 12, 2025
Completion date
June 1, 2026
Enrollment
178 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

migraine